|
|
|
|
|
|
|
|
|
|
"Dendreon is using cancer immunotherapies that use the patient's own immune system to treat cancer and the approval of Provenge represents a scientific and clinical advancement for the treatment of prostate cancer.
Prima BioMed, an Australian biotechnology firm focused on cancer immunotherapy, is using the technology to develop its CVac immunotherapy cancer vaccine for the treatment of ovarian cancer."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.